Back to all Programs

Past Event

Related Materials

Past Event

Chinese HIV Clinical Forum 2022

Resistance Considerations in Choice of Regimen - Kiat Ruxrungtham, MD

HIV Low-Level Viremia and New Approach to Drug Resistance Surveillance - Fujie Zhang, MD, PhD

Pharmacological Considerations in Choice of Regimen - Andrea Calcagno, MD, DTM&H

Switching to Newer (Reduced) Drug Regimens in Patients Suppressed on Older Drugs - Nicholas Paton, MD, FRCP

Update on Long Acting Therapeutic Options for HIV Treatment - Jean-Michel Molina, MD, PhD

Stopping/Switching Considerations When Using La-ARVs - Marta Boffito, MD, PhD, FRCP

International Data Supporting Rapid Start - Chien-Ching Hung, MD, PhD

Rapid ART Initiation Using BIC/FTC/TAF and TDF+3TC+EFV in HIV Positive Patients in China: A Randomized Controlled Trial - Lili Dai, PhD

Clinical Case (focused on starting and switching therapy) - Wei Lyu, PhD